VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2020/02/29	08:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/28	07:35	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation at March 2020 Investor Conferences	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/26	22:55	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/26	21:03	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/26	06:13	PR Newswire (US)	Vanda Reports results from the EPIONE study of Tradipitant in the treatment of Pruritus in Atopic Dermatitis	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/26	06:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/26	06:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/21	06:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/20	06:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/20	06:20	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/19	21:00	PR Newswire (US)	Vanda Pharmaceuticals Appoints Stephen Ray Mitchell to Board of Directors	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/19	20:13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/19	10:22	PR Newswire (US)	Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/15	06:07	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/15	05:19	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/15	01:10	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/14	06:40	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/13	03:49	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/12	23:25	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/05	02:35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/03	20:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/02/01	08:24	PR Newswire (US)	Vanda Pharmaceuticals Comments on Court Ruling	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/01/22	06:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/01/14	07:19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/01/14	04:11	PR Newswire (US)	Vanda Pharmaceuticals Wins Key U.S. Supreme Court Patent Ruling on Fanapt®	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/01/07	07:27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/01/07	07:27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/01/07	07:26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2020/01/07	07:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2019/12/14	06:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc